[HTML][HTML] mRNA vaccines for COVID-19: what, why and how

JW Park, PNP Lagniton, Y Liu… - International journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The Coronavirus disease-19 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has impacted human lives in the most …

COVID-19 mRNA vaccines: Platforms and current developments

GT Szabó, AJ Mahiny, I Vlatkovic - Molecular Therapy, 2022 - cell.com
Since the first successful application of messenger ribonucleic acid (mRNA) as a vaccine
agent in a preclinical study nearly 30 years ago, numerous advances have been made in …

mRNA vaccines in the COVID-19 pandemic and beyond

MJ Hogan, N Pardi - Annual review of medicine, 2022 - annualreviews.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus
disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around …

The development of mRNA vaccines for infectious diseases: recent updates

Nitika, J Wei, AM Hui - Infection and drug resistance, 2021 - Taylor & Francis
Abstract mRNA-based technologies have been of interest for the past few years to be used
for therapeutics. Several mRNA vaccines for various diseases have been in preclinical and …

mRNA vaccines against SARS-CoV-2: Advantages and caveats

M Echaide, L Chocarro de Erauso… - International Journal of …, 2023 - mdpi.com
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …

mRNA-based vaccine for COVID-19: they are new but not unknown!

VP Chavda, G Jogi, S Dave, BM Patel, L Vineela Nalla… - Vaccines, 2023 - mdpi.com
mRNA vaccines take advantage of the mechanism that our cells use to produce proteins.
Our cells produce proteins based on the knowledge contained in our DNA; each gene …

An insight overview on COVID-19 mRNA vaccines: advantageous, pharmacology, mechanism of action, and prospective considerations

MS Mirtaleb, R Falak, J Heshmatnia… - International …, 2023 - Elsevier
The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has urged scientists to present some novel vaccine platforms during this pandemic to …

The importance of RNA-based vaccines in the fight against COVID-19: an overview

BAS Machado, KVS Hodel, LMS Fonseca… - Vaccines, 2021 - mdpi.com
In recent years, vaccine development using ribonucleic acid (RNA) has become the most
promising and studied approach to produce safe and effective new vaccines, not only for …

Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic

S Jain, A Venkataraman, ME Wechsler… - Advanced drug delivery …, 2021 - Elsevier
Abstract mRNA vaccines have received major attention in the fight against COVID-19.
Formulations from companies such as Moderna and BioNTech/Pfizer have allowed us to …

mRNA vaccines for COVID-19 and diverse diseases

A Hussain, H Yang, M Zhang, Q Liu, G Alotaibi… - Journal of Controlled …, 2022 - Elsevier
Since its outbreak in late 2019, the novel coronavirus disease 2019 (COVID-19) has spread
to every continent on the planet. The global pandemic has affected human health and …